IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ROSSOTTI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.348
EU - Europa 1.326
NA - Nord America 1.202
SA - Sud America 144
AF - Africa 43
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.070
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.133
IT - Italia 459
SG - Singapore 364
CN - Cina 345
VN - Vietnam 280
DE - Germania 258
GB - Regno Unito 181
HK - Hong Kong 114
BR - Brasile 113
BD - Bangladesh 82
RU - Federazione Russa 82
SE - Svezia 77
FR - Francia 52
CA - Canada 49
IN - India 49
NL - Olanda 42
ES - Italia 32
FI - Finlandia 30
IE - Irlanda 28
TR - Turchia 21
CI - Costa d'Avorio 17
KR - Corea 17
JP - Giappone 14
MX - Messico 14
IQ - Iraq 12
PL - Polonia 12
CH - Svizzera 11
ID - Indonesia 10
UA - Ucraina 10
PH - Filippine 9
AT - Austria 8
DK - Danimarca 8
BE - Belgio 7
CO - Colombia 7
AR - Argentina 6
AU - Australia 6
MK - Macedonia 5
RO - Romania 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
CL - Cile 4
TW - Taiwan 4
CZ - Repubblica Ceca 3
ET - Etiopia 3
GR - Grecia 3
KZ - Kazakistan 3
NG - Nigeria 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
SI - Slovenia 3
UY - Uruguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
EC - Ecuador 2
EU - Europa 2
GA - Gabon 2
GP - Guadalupe 2
LK - Sri Lanka 2
MA - Marocco 2
NP - Nepal 2
OM - Oman 2
PK - Pakistan 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
EG - Egitto 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LY - Libia 1
MY - Malesia 1
PA - Panama 1
RW - Ruanda 1
SA - Arabia Saudita 1
SN - Senegal 1
UG - Uganda 1
Totale 4.072
Salva come PNG Salva come JPEG
Città #
Singapore 216
Frankfurt am Main 177
Ashburn 158
Southend 134
Dallas 124
Milan 117
Chandler 104
Hong Kong 94
Ho Chi Minh City 82
San Jose 78
Hanoi 61
Beijing 57
Rome 54
New York 48
Council Bluffs 41
Los Angeles 37
Toronto 32
Hefei 30
Da Nang 29
Hanover 29
Dublin 28
Princeton 26
Santa Clara 26
Boardman 19
Lauterbourg 19
Moscow 18
Redwood City 18
Abidjan 17
Bologna 17
Houston 17
Seattle 16
São Paulo 16
Wilmington 15
Buffalo 14
Naples 14
Bengaluru 13
Helsinki 13
Haiphong 11
Munich 11
Tokyo 11
Warsaw 11
Cangzhou 10
Grafing 10
Phoenix 10
Seoul 10
Shanghai 10
Cambridge 9
Des Moines 9
Istanbul 9
Jakarta 9
Jinan 9
London 9
Atlanta 8
The Dalles 8
Turku 8
Ann Arbor 7
Chicago 7
City of London 7
Hillsboro 7
Palermo 7
Thái Nguyên 7
Washington 7
Woodbridge 7
Ancona 6
Baghdad 6
Barcelona 6
Bắc Ninh 6
Changsha 6
Elk Grove Village 6
Fairfield 6
Lappeenranta 6
Mumbai 6
Shenzhen 6
Wuhan 6
Amsterdam 5
Berlin 5
Chennai 5
Dearborn 5
Denver 5
Fuzhou 5
Guangzhou 5
Jacksonville 5
Jerez de la Frontera 5
Nuremberg 5
Paris 5
Reston 5
Salerno 5
Skopje 5
Bibbiano 4
Biên Hòa 4
Can Tho 4
Carlentini 4
Columbus 4
Dong Ket 4
Fremont 4
Hangzhou 4
Izmir 4
Madrid 4
Pavia 4
Quanzhou 4
Totale 2.420
Salva come PNG Salva come JPEG
Nome #
Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients 489
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 284
The impact of HIV infection and men who have sex with men status on hepatitis A infection: The experience of two tertiary centres in Northern Italy during the 2017 outbreak and in the 2009-2016 period 252
Outbreak of Acute Hepatitis A involving young men in Lombardy region, Italy: Risk factors, clinical and virological characteristics 250
Determinants of worse liver‐related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort 243
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 215
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 204
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 200
Outbreak of acute hepatitis A involving young men in Lombardy Region, Italy: risk factors, clinical and virological characteristics 193
Efficacy and resistance of recently developed non-nucleoside reverse transcriptase inhibitors for HIV-1 191
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 181
Unconventional use of injectable long-acting cabotegravir and rilpivirine against HIV-1 in PWH in clinical need: 52 weeks real-world data 143
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort 136
Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy 135
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort 134
Rilpivirine resistance and the dangerous liaisons with substitutions at position 184 among patients infected with HIV-1: analysis from a national drug-resistance database (ARCA) 134
Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy : Modeling from antiretroviral resistance cohort analysis (ARCA) national database 134
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500,000 copies/mL in 2018-2023 in Italy: data from the ICONA Foundation Cohort Study 122
HIV infection among adolescents and young adults in Italy: epidemiology, viro-immunological and treatment outcomes 112
The use of intrahepatic portosystemic shunt in HIV positive patients : A retrospective multicentric study 110
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 89
Outbreak of Vancomycin-Resistant Enterococcus in a NICU: Insights into Molecular Detection and Infection Control 73
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 71
Brief Report: New HIV Diagnoses in PrEP-Experienced and PrEP-Naive Persons in the ICONA Cohort 58
Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 Infection 46
Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort 10
Totale 4.209
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.791
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 0 0 25
2021/2022257 8 16 16 12 16 3 28 34 46 27 8 43
2022/2023293 41 40 20 22 31 44 2 19 44 6 20 4
2023/2024292 1 13 12 10 47 18 32 23 21 26 46 43
2024/2025687 42 72 36 86 30 28 35 44 54 76 65 119
2025/20262.140 148 158 213 195 128 124 375 116 211 194 242 36
Totale 4.209